56 filings
ARS
2023 FY
INKT
MiNK Therapeutics Inc
29 Apr 24
Annual report to shareholders
6:10pm
DEF 14A
INKT
MiNK Therapeutics Inc
Definitive proxy
29 Apr 24
5:25pm
10-K
2023 FY
INKT
MiNK Therapeutics Inc
Annual report
21 Mar 24
4:05pm
8-K
INKT
MiNK Therapeutics Inc
21 Mar 24
MiNK Reports Fourth Quarter and Year-End 2023 Results
7:00am
8-K
INKT
MiNK Therapeutics Inc
29 Feb 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
8-K
bc36z
14 Feb 24
Entry into a Material Definitive Agreement
8:00am
8-K
87j7d8ffx657lf7
9 Nov 23
MiNK Therapeutics Reports Third Quarter 2023 Results
7:00am
8-K
7qg5wmeh
17 Oct 23
Departure of Directors or Certain Officers
4:15pm
S-8
apx4kgu2dtqtgrfr
11 Aug 23
Registration of securities for employees
7:44am
8-K
nffx2
10 Aug 23
MiNK Therapeutics Reports Second Quarter 2023 Results
7:30am
8-K
ghkfptxhbhlcnuj6e
20 Jun 23
Submission of Matters to a Vote of Security Holders
3:45pm
8-K
p0y rerxu2
11 May 23
MiNK Therapeutics Reports Corporate Update and First Quarter 2023 Financial Results
8:00am
8-K
aeghif
21 Mar 23
MiNK Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results
8:00am
EFFECT
dxg913ohl
9 Nov 22
Notice of effectiveness
12:15am
UPLOAD
sl6ddtubhzslw9
7 Nov 22
Letter from SEC
12:00am